These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 18264947)

  • 1. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?
    Fares F; Badarneh K; Abosaleh M; Harari-Shaham A; Diukman R; David M
    Prenat Diagn; 2008 Mar; 28(3):236-41. PubMed ID: 18264947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
    Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
    Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bloom syndrome and Fanconi's anemia: rate and ethnic origin of mutation carriers in Israel.
    Peleg L; Pesso R; Goldman B; Dotan K; Omer M; Friedman E; Berkenstadt M; Reznik-Wolf H; Barkai G
    Isr Med Assoc J; 2002 Feb; 4(2):95-7. PubMed ID: 11876000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-based carrier screening in the Ashkenazi Jewish population.
    Zhang B; Dearing L; Amos J
    Expert Rev Mol Diagn; 2004 May; 4(3):377-92. PubMed ID: 15137904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of breast and colorectal cancer in Ashkenazi Jewish carriers of Fanconi anemia and Bloom syndrome.
    Baris HN; Kedar I; Halpern GJ; Shohat T; Magal N; Ludman MD; Shohat M
    Isr Med Assoc J; 2007 Dec; 9(12):847-50. PubMed ID: 18210922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frequency of mucolipidosis type IV in the Ashkenazi Jewish population and the identification of 3 novel MCOLN1 mutations.
    Bach G; Webb MB; Bargal R; Zeigler M; Ekstein J
    Hum Mutat; 2005 Dec; 26(6):591. PubMed ID: 16287144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ashkenazi Jewish Fanconi anemia mutation: incidence among patients and carrier frequency in the at-risk population.
    Whitney MA; Jakobs P; Kaback M; Moses RE; Grompe M
    Hum Mutat; 1994; 3(4):339-41. PubMed ID: 8081385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive population screening in the Ashkenazi Jewish population for recurrent disease-causing variants.
    Shi L; Webb BD; Birch AH; Elkhoury L; McCarthy J; Cai X; Oishi K; Mehta L; Diaz GA; Edelmann L; Kornreich R
    Clin Genet; 2017 Apr; 91(4):599-604. PubMed ID: 27415407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ashkenazi Jewish population frequency of the Bloom syndrome gene 2281 delta 6ins7 mutation.
    Roa BB; Savino CV; Richards CS
    Genet Test; 1999; 3(2):219-21. PubMed ID: 10464671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population screening for carrier status: effects of test limitations on precision of carrier prevalence rates.
    Parker RA; Phillips JA
    Am J Med Genet; 1994 Feb; 49(3):317-22. PubMed ID: 8209893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for familial dysautonomia in Israel: evidence for higher carrier rate among Polish Ashkenazi Jews.
    Lehavi O; Aizenstein O; Bercovich D; Pavzner D; Shomrat R; Orr-Urtreger A; Yaron Y
    Genet Test; 2003; 7(2):139-42. PubMed ID: 12885336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel.
    Broide E; Zeigler M; Eckstein J; Bach G
    Am J Med Genet; 1993 Aug; 47(2):213-5. PubMed ID: 8213907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin.
    Shahrabani-Gargir L; Shomrat R; Yaron Y; Orr-Urtreger A; Groden J; Legum C
    Genet Test; 1998; 2(4):293-6. PubMed ID: 10464606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools.
    Ioannou L; Massie J; Lewis S; Petrou V; Gason A; Metcalfe S; Aitken MA; Bankier A; Delatycki MB
    Clin Genet; 2010 Jul; 78(1):21-31. PubMed ID: 20597919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases.
    Scott SA; Edelmann L; Liu L; Luo M; Desnick RJ; Kornreich R
    Hum Mutat; 2010 Nov; 31(11):1240-50. PubMed ID: 20672374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D; Jansen V; Ostrer H
    Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier frequency of two BBS2 mutations in the Ashkenazi population.
    Fedick A; Jalas C; Abeliovich D; Krakinovsky Y; Ekstein J; Ekstein A; Treff NR
    Clin Genet; 2014 Jun; 85(6):578-82. PubMed ID: 23829372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower frequency of Gaucher disease carriers among Tay-Sachs disease carriers.
    Peleg L; Frisch A; Goldman B; Karpaty M; Narinsky R; Bronstein S; Frydman M
    Eur J Hum Genet; 1998; 6(2):185-6. PubMed ID: 9781065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier testing for autosomal-recessive disorders.
    Vallance H; Ford J
    Crit Rev Clin Lab Sci; 2003 Aug; 40(4):473-97. PubMed ID: 14582604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier frequency of the Bloom syndrome blmAsh mutation in the Ashkenazi Jewish population.
    Li L; Eng C; Desnick RJ; German J; Ellis NA
    Mol Genet Metab; 1998 Aug; 64(4):286-90. PubMed ID: 9758720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.